Literature DB >> 2118929

Adverse immune reactions to gold. I. Chronic treatment with an Au(I) drug sensitizes mouse T cells not to Au(I), but to Au(III) and induces autoantibody formation.

D Schuhmann1, M Kubicka-Muranyi, J Mirtschewa, J Günther, P Kind, E Gleichmann.   

Abstract

Upon weekly i.m. injections of disodium gold thiomalate (Na2AuTM) 100% of A.SW mice produced IgG autoantibodies to antinuclear Ag and nucleolar Ag, respectively; about 70% of C57BL/6 mice produced IgG antinuclear Ag, whereas DBA/2 mice were resistant. Moreover, C57BL/6 mice, but not DBA/2 mice, showed increased mesangial deposits of IgG. These alterations were due not to disodium thiomalate, but to the gold ion of Na2AuTM. An assumed T cell reactivity of susceptible mouse strains to Na2AuTM was tested by means of the direct popliteal lymph node (PLN) assay. However, no distinct PLN reaction to Na2AuTM was detectable. Likewise, AuCl did not induce a PLN reaction. Both Na2AuTM and AuCl contain gold in the Au(I) state. The poor PLN responses to Au(I) contrasted with the strong PLN responses to Au(III) compounds. PLN reactions to Au(III) were dose dependent, T cell dependent, and specific. When Au(III) was reduced to Au(I) by addition of Na2TM or methionine before testing in the PLN assay its sensitizing capacity was significantly decreased. Thus, the oxidation state of gold, i.e., Au(III) vs Au(I), plays a major role for its sensitizing capacity. Therefore, we propose that the Au(I) of Na2AuTM is oxidized to Au(III) before T cells are sensitized and adverse immunologic reactions develop. Results obtained with the adoptive transfer PLN assay indicated that, indeed, repeated i.m. injections of Na2AuTM sensitized A.SW and C57BL/6 splenic T cells to Au(III).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2118929

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Insights into the mechanism of gold action provided by immunotoxicology: biooxidation of gold(I) to gold(III) detected by sensitized T-cells.

Authors:  E Gleichmann; M Kubicka-Muranyi; P Kind; R Goldermann; G Goerz; H Merk; R Rau
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

2.  Gold-specific T cells in rheumatoid arthritis patients treated with gold.

Authors:  P Romagnoli; G A Spinas; F Sinigaglia
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

Review 3.  Corrosion of Metallic Biomaterials: A Review.

Authors:  Noam Eliaz
Journal:  Materials (Basel)       Date:  2019-01-28       Impact factor: 3.623

4.  Genetic linkage of IgA deficiency to the major histocompatibility complex: evidence for allele segregation distortion, parent-of-origin penetrance differences, and the role of anti-IgA antibodies in disease predisposition.

Authors:  I Vorechovský; A D Webster; A Plebani; L Hammarström
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

Review 5.  Metal nanomaterials: Immune effects and implications of physicochemical properties on sensitization, elicitation, and exacerbation of allergic disease.

Authors:  Katherine A Roach; Aleksandr B Stefaniak; Jenny R Roberts
Journal:  J Immunotoxicol       Date:  2019-12       Impact factor: 3.000

6.  Selective induction of anti-fibrillarin autoantibodies by silver nitrate in mice.

Authors:  P Hultman; S Eneström; S J Turley; K M Pollard
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

7.  Gold induced nephropathy in rheumatoid arthritis and HLA class II genes.

Authors:  L I Sakkas; I C Chikanza; R W Vaughan; K I Welsh; G S Panayi
Journal:  Ann Rheum Dis       Date:  1993-04       Impact factor: 19.103

8.  A T-cell response to the anti-arthritic drug penicillamine in the mouse: requirements for generation of the drug-derived antigen.

Authors:  C A O'Donnell; J W Coleman
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

9.  Phagocytes render chemicals immunogenic: oxidation of gold(I) to the T cell-sensitizing gold(III) metabolite generated by mononuclear phagocytes.

Authors:  C Goebel; M Kubicka-Muranyi; T Tonn; J Gonzalez; E Gleichmann
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

10.  Polyclonal human T-cell activation by silicate in vitro.

Authors:  A Ueki; M Yamaguchi; H Ueki; Y Watanabe; G Ohsawa; K Kinugawa; Y Kawakami; F Hyodoh
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.